Kintor has started Phase 3 trial in China for Pyrilutamide

Ljames

Member
My Regimen
Reaction score
24
Bad news guys. Kintor has delayed the publication of phase II results again to September 2022.
Unfortunately, really looks like an other scam.
I don't understand why you would progress to phase 3 and the costs involved in that if you're aware the phase 2 results are lacking
 

Hard_science_only

New Member
My Regimen
Reaction score
1
I don't understand why you would progress to phase 3 and the costs involved in that if you're aware the phase 2 results are lacking
Probably to keep the stock price elevated till they can raise new funds, management can cash out, other product candidates can progress to more promising stages etc.
 

klbt

New Member
My Regimen
Reaction score
5

Attachments

  • 90d3546a-4986-4edb-bf09-d84df6457465.png
    90d3546a-4986-4edb-bf09-d84df6457465.png
    245.3 KB · Views: 196

RagnarLothbrok

Established Member
My Regimen
Reaction score
351
That's the whole point; the trial is finished ages ago but for some reason they keep delaying its publication. It is obviously a financial decision. Hopefully it is because the results are so f*****g good that they want to inside trade before publishing. But lets be honest, most likely the results aren't good.
 

Tom4362

Established Member
My Regimen
Reaction score
512
That's the whole point; the trial is finished ages ago but for some reason they keep delaying its publication. It is obviously a financial decision. Hopefully it is because the results are so f*****g good that they want to inside trade before publishing. But lets be honest, most likely the results aren't good.
We already have the results, they leaked. Increase in haircount was similar to finasteride
 

RagnarLothbrok

Established Member
My Regimen
Reaction score
351
Honestly, its 1th June and there is 0 official sources confirming they pushed back to September (just random new forum user claiming it).
Only way we can know is waiting this month out for now.
Hopefully its fake news and all on track.
 
Top